33 results
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
efforts and support our operations as a U.S. public company listed on Nasdaq;
expand our operations and potentially hire additional employees … could hinder their ability to hire, retain or deploy key leadership and other personnel, prevent new or modified products from being developed, review
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
2 Nov 21
Current report (foreign)
4:16pm
basket study for etigilimab and our ongoing Phase 2 proof-of-concept trial for alvelestat; hire additional clinical, scientific, and commercial
6-K
EX-10.1
k8az7pq cxcg7kdh9
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am
F-1/A
rc9cgqt
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
silhifv8lk7dwr5b5
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
F-1
lqrkju xej2
18 Feb 20
Registration statement (foreign)
5:15pm
6-K
EX-99.1
83wlr47v5ptf atcaj
22 Nov 19
Current report (foreign)
9:29am
6-K
ko6q9vud5uwu5ogre
17 Sep 19
Current report (foreign)
8:06am
6-K
EX-99.1
65844r7r
17 Sep 19
Current report (foreign)
8:06am
6-K
EX-10.1
6731nklc tbswcd6v
3 Sep 19
Current report (foreign)
4:05pm
20-F
otf9m
29 Apr 19
Annual report (foreign)
4:59pm
20-F
EX-4.13.1
33bo9qexwi zgy
29 Apr 19
Annual report (foreign)
4:59pm
6-K
xpl8bupe3wmx
23 Apr 19
Current report (foreign)
4:14pm